J.M. Arbour’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$320K Buy
11,208
+765
+7% +$20.3K 0.26% 100
2026
Q2
$251K Buy
10,443
+1,286
+14% +$33.6K 0.22% 112
2026
Q1
$257K Buy
9,157
+351
+4% +$9.34K 0.25% 101
2025
Q4
$219K Buy
+8,806
New +$222K 0.22% 105

Other funds holding PFE

J.M. Arbour's PFE Position: Q3 2026 in Review

J.M. Arbour increased its Pfizer (PFE) stake by 7.3% in Q3 2026, buying an estimated $20.3K and bringing the position to 11,208 shares worth $320K. The position accounts for 0.26% of the portfolio, ranked #100.

J.M. Arbour first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,843 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • J.M. Arbour held 11,208 shares of Pfizer worth $320K as of Q3 2026.
  • J.M. Arbour bought 765 Pfizer shares in Q3 2026, an estimated $20.3K.
  • Pfizer made up 0.26% of J.M. Arbour's portfolio in Q3 2026, its #100 holding.
  • J.M. Arbour first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,843 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on J.M. Arbour's 13F filing for Q3 2026, filed 5 Nov 2026.